SEARCH

SEARCH BY CITATION

References

  • Acher F., Selvam C., Triballeau N., Pin J.-P. and Bertrand H.-O. (2007) Hypophosphorous acid derivatives and their therapeutical applications. International Patent Application. WO2007052169, pp. 109, 10 May 2007.
  • Albin R. L., Young A. B. and Penney J. B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366375.
  • Ayala J. E., Niswender C. M., Luo Q., Banko J. L. and Conn P. J. (2008) Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated. Neuropharmacology 54, 804814.
  • Blandini F., Porter R. H. and Greenamyre J. T. (1996) Glutamate and Parkinson’s disease. Mol. Neurobiol. 12, 7394.
  • Bracci E. and Panzeri S. (2006) Excitatory GABAergic effects in striatal projection neurons. J. Neurophysiol. 95, 12851290.
  • Bradley S. R., Standaert D. G., Rhodes K. J., Rees H. D., Testa C. M., Levey A. I. and Conn P. J. (1999) Immunohistochemical localization of subtype 4a metabotropic glutamate receptors in the rat and mouse basal ganglia. J. Comp. Neurol. 407, 3346.
  • Bruet N., Windels F., Carcenac C., Feuerstein C., Bertrand A., Poupard A. and Savasta M. (2003) Neurochemical mechanisms induced by high frequency stimulation of the subthalamic nucleus: increase of extracellular striatal glutamate and GABA in normal and hemiparkinsonian rats. J. Neuropathol. Exp. Neurol. 62, 12281240.
  • Calabresi P., Mercuri N. B. and Bernardi G. (1990) Synaptic and intrinsic control of membrane excitability of neostriatal neurons. II. An in vitro analysis. J. Neurophysiol. 63, 663675.
  • Calabresi P., Mercuri N. B., Sancesario G. and Bernardi G. (1993) Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson’s disease. Brain 116, 433452.
  • Calabresi P., Centonze D., Gubellini P., Marfia G. A., Pisani A., Sancesario G. and Bernardi G. (2000) Synaptic transmission in the striatum: from plasticity to neurodegeneration. Prog. Neurobiol. 61, 231265.
  • Chase L. A., Roon R. J., Wellman L., Beitz A. J. and Koerner J. F. (2001) L-Quisqualic acid transport into hippocampal neurons by a cystine-sensitive carrier is required for the induction of quisqualate sensitization. Neuroscience 106, 287301.
  • Chen M. T., Morales M., Woodward D. J., Hoffer B. J. and Janak P. H. (2001) In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions. Exp. Neurol. 171, 7283.
  • Conn P. J. and Pin J.-P. (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37, 205237.
  • Conn P. J., Battaglia G., Marino M. J. and Nicoletti F. (2005) Metabotropic glutamate receptors in the basal ganglia motor circuits. Nat. Rev. Neurosci. 6, 787798.
  • Corti C., Restituito S., Rimland J. M., Brabet I., Corsi M., Pin J.-P. and Ferraguti F. (1998) Cloning and characterization of alternative mRNA forms for the rat metabotropic glutamate receptors mGluR7 and mGluR8. Eur. J. Neurosci. 10, 36293641.
  • Corti C., Aldegheri P., Somogyi P. and Ferraguti F. (2002) Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS. Neuroscience 110, 403420.
  • Cossart R., Hirsch J. C., Cannon R. C., Dinoncourt C., Wheal H. V., Ben-Ari Y., Esclapez M. and Bernard C. (2000) Distribution of spontaneous currents along the somato-dendritic axis of rat hippocampal CA1 pyramidal neurons. Neuroscience 99, 593603.
  • Czubayko U. and Plenz D. (2002) Fast synaptic transmission between striatal spiny projection neurons. Proc. Natl Acad. Sci. USA 99, 1576415769.
  • Ferraguti F. and Shigemoto R. (2006) Metabotropic glutamate receptors. Cell Tissue Res. 326, 483504.
  • Ghasemzadeh M. B., Sharma S., Surmeier D. J., Eberwine J. H. and Chesselet M. F. (1996) Multiplicity of glutamate receptor subunits in single striatal neurons: an RNA amplification study. Mol. Pharmacol. 49, 852859.
  • Gill H. S. and Eisenberg D. (2001) The crystal structure of phosphinothricin in the active site of glutamine synthetase illuminates the mechanism of enzymatic inhibition. Biochemistry 40, 19031912.
  • Graybiel A. M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13, 244254.
  • Greenamyre J. T. (2001) Glutamatergic influences on the basal ganglia. Clin. Neuropharmacol. 24, 6570.
  • Groves P. M. (1983) A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement. Brain Res. Rev. 5, 109132.
  • Gubellini P., Picconi B., Bari M., Battista N., Calabresi P., Centonze D., Bernardi G., Finazzi-Agrò A. and Maccarrone M. (2002) Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J. Neurosci. 22, 69006907.
  • Gubellini P., Pisani A., Centonze D., Bernardi G. and Calabresi P. (2004) Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases. Prog. Neurobiol. 74, 271300.
  • Gubellini P., Eusebio A., Oueslati A., Melon C., Kerkerian-Le Goff L. and Salin P. (2006) Chronic high-frequency stimulation of the subthalamic nucleus and L-DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission. Eur. J. Neurosci. 24, 18021814.
  • Gustafson N., Gireesh-Dharmaraj E., Czubayko U., Blackwell K. T. and Plenz D. (2006) A comparative voltage and current-clamp analysis of feedback and feedforward synaptic transmission in the striatal microcircuit in vitro. J. Neurophysiol. 95, 737752.
  • Ingham C. A., Hood S. H., Mijnster M. J., Baldock R. A. and Arbuthnott G. W. (1997) Plasticity of striatopallidal terminals following unilateral lesion of the dopaminergic nigrostriatal pathway: a morphological study. Exp. Brain Res. 116, 3949.
  • Kinoshita A., Shigemoto R., Ohishi H., Van Der Putten H. and Mizuno N. (1998) Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: a light and electron microscopic study. J. Comp. Neurol. 393, 332352.
  • Koos T., Tepper J. M. and Wilson C. J. (2004) Comparison of IPSCs evoked by spiny and fast-spiking neurons in the neostriatum. J. Neurosci. 24, 79167922.
  • Kosinski C. M., Risso Bradley S., Conn P. J., Levey A. I., Landwehrmeyer G. B., Penney J. B. Jr, Young A. B. and Standaert D. G. (1999) Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia. J. Comp. Neurol. 415, 266284.
  • Krajewski W. W., Collins R., Holmberg-Schiavone L., Jones T. A., Karlberg T. and Mowbray S. L. (2008) Crystal structures of mammalian glutamine synthetases illustrate substrate-induced conformational changes and provide opportunities for drug and herbicide design. J. Mol. Biol. 375, 217228.
  • Levy R., Hazrati L. N., Herrero M. T. et al. (1997) Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states. Neuroscience 76, 335343.
  • Lopez S., Turle-Lorenzo N., Acher F., De Leonibus E., Mele A. and Amalric M. (2007) Targeting group III metabotropic glutamate receptors produces complex behavioral effects in rodent models of Parkinson’s disease. J. Neurosci. 27, 67016711.
  • Marino M. J., Williams D. L. Jr, O’Brien J. A. et al. (2003) Allosteric modulation of group III metabotropic glutamate receptor 4: a potential approach to Parkinson’s disease treatment. Proc. Natl Acad. Sci. USA 100, 1366813673.
  • Matsui T. and Kita H. (2003) Activation of group III metabotropic glutamate receptors presynaptically reduces both GABAergic and glutamatergic transmission in the rat globus pallidus. Neuroscience 122, 727737.
  • Messenger M. J., Dawson L. G. and Duty S. (2002) Changes in metabotropic glutamate receptor 1-8 gene expression in the rodent basal ganglia motor loop following lesion of the nigrostriatal tract. Neuropharmacology 43, 261271.
  • Mora F., Segovia G. and Del Arco A. (2007) Glutamate-dopamine-GABA interactions in the aging basal ganglia. Brain Res. Rev. 58, 340353.
  • Niswender C. M., Johnson K. A., Weaver C. D. et al. (2008) Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4. Mol. Pharmacol. 74, 13451358.
  • Orr W. B., Stricker E. M., Zigmond M. J. and Berger T. W. (1987) Effects of dopamine depletion on the spontaneous activity of type I striatal neurons: relation to local dopamine concentration and motor behavior. Synapse 1, 461469.
  • Pekhletski R., Gerlai R., Overstreet L. S., Huang X. P., Agopyan N., Slater N. T., Abramow-Newerly W., Roder J. C. and Hampson D. R. (1996) Impaired cerebellar synaptic plasticity and motor performance in mice lacking the mGluR4 subtype of metabotropic glutamate receptor. J. Neurosci. 16, 63646373.
  • Picconi B., Centonze D., Rossi S., Bernardi G. and Calabresi P. (2004) Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism. Brain 127, 16611669.
  • Pin J.-P. and Acher F. (2002) The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. Curr. Drug Targets CNS Neurol. Disord. 1, 297317.
  • Pisani A., Calabresi P., Centonze D. and Bernardi G. (1997) Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse. Neurophamacology 36, 845851.
  • Rouse S. T., Marino M. J., Bradley S. R., Awad H., Wittmann M. and Conn P. J. (2000) Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson’s disease and related disorders. Pharmacol. Ther. 88, 427435.
  • Saugstad J. A., Kinzie J. M., Shinohara M. M., Segerson T. P. and Westbrook G. L. (1997) Cloning and expression of rat metabotropic glutamate receptor 8 reveals a distinct pharmacological profile. Mol. Pharmacol. 51, 119125.
  • Schulte M. K., Whittemore E. R., Koerner J. F. and Johnson R. L. (1992) Structure-function relationships for analogues of L-2-amino-4-phosphonobutanoic acid on the quisqualic acid-sensitive AP4 receptor of the rat hippocampus. Brain Res. 582, 291298.
  • Schwartig R. K. W. and Huston J. P. (1996) The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Prog. Neurobiol. 50, 275231.
  • Selvam C., Goudet C., Oueslati N., Pin J.-P. and Acher F. (2007) L(+)-2-amino-4-thiophosphonobutyric acid (L-thioAP4), a new potent agonist of group III metabotropic glutamate receptors: increased distal acidity affords enhanced potency. J. Med. Chem. 50, 46564664.
  • Smith A. D. and Bolam J. P. (1990) The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci. 13, 259265.
  • Soghomonian J. J. and Laprade N. (1997) Glutamate decarboxylase (GAD67 and GAD65) gene expression is increased in a subpopulation of neurons in the putamen of parkinsonian monkeys. Synapse 27, 122132.
  • Taverna S., Ilijic E. and Surmeier D. J. (2008) Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson’s disease. J. Neurosci. 28, 55045512.
  • Tepper J. M. and Bolam J. P. (2004) Functional diversity and specificity of neostriatal interneurons. Curr. Opin. Neurobiol. 14, 685692.
  • Tepper J. M., Koos T. and Wilson C. J. (2004) GABAergic microcircuits in the neostriatum. Trends Neurosci. 27, 662669.
  • Testa C. M., Standaert D. G., Young A. B. and Penney J. B. Jr (1994) Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J. Neurosci. 14, 30053018.
  • Thomas N. K., Wright R. A., Howson P. A., Kingston A. E., Schoepp D. D. and Jane D. E. (2001) (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord. Neuropharmacology 40, 311318.
  • Triballeau N., Acher F., Brabet I., Pin J.-P. and Bertrand H.-O. (2005) Virtual screening workflow development guided by the ROC curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. J. Med. Chem. 48, 25342547.
  • Tseng K. Y., Kasanetz F., Kargieman L., Riquelme L. A. and Murer M. G. (2001) Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions. J. Neurosci. 21, 64306439.
  • Tunstall M. J., Oorschot D. E., Kean A. and Wickens J. R. (2002) Inhibitory interactions between spiny projection neurons in the rat striatum. J. Neurophysiol. 88, 12631269.
  • Valenti O., Marino M. J., Wittmann M., Lis E., DiLella A. G., Kinney G. G. and Conn P. J. (2003) Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse. J. Neurosci. 23, 72187226.
  • Valenti O., Mannaioni G., Seabrook G. R., Conn P. J. and Marino M. J. (2005) Group III metabotropic glutamate-receptor-mediated modulation of excitatory transmission in rodent substantia nigra pars compacta dopamine neurons. J. Pharmacol. Exp. Ther. 313, 12961304.
  • Venance L., Glowinski J. and Giaume C. (2004) Electrical and chemical transmission between striatal GABAergic output neurones in rat brain slices. J. Physiol. (Lond.) 559, 215230.
  • Wichmann T. and DeLong M. R. (1996) Functional and pathophysiological models of the basal ganglia. Curr. Opin. Neurobiol. 6, 751758.
  • Wichmann T. and DeLong M. R. (1998) Models of basal ganglia function and pathophysiology of movement disorders. Neurosurg. Clin. N. Am. 9, 223236.
  • Wittmann M., Marino M. J., Bradley S. R. and Conn P. J. (2001) Activation of group III mGluRs inhibits GABAergic and glutamatergic transmission in the substantia nigra pars reticulata. J. Neurophysiol. 85, 19601968.